Canadian Life Sciences AI Summit

September 28, 2026 | Fairmont Château Laurier, Ottawa

The Canadian Biotech Consortium invites you to the national summit defining Canada's AI-powered ecosystem for clinical research, precision medicine, and biomanufacturing.

Designed for decision-makers across biotech, pharmaceuticals, government, healthcare delivery, and capital markets, this one-day executive forum delivers actionable insights, policy alignment, and high-level strategic networking.

Why Attend:

• Benchmark Strategies: Explore how AI is actively streamlining regulatory pathways and drug discovery.
• Drive System Transformation: Participate in cross-sector dialogue on national data infrastructure and scaling innovation.
• Connect with Capital: Engage with leading investors and institutional funders backing Canadian health tech.

Registration and Call for Abstracts:

Space is limited to maintain an intimate setting for executive dialogue. Secure your pass today by purchasing a ticket through Evenbrite.

We are now accepting abstracts submissions for presentations. Please submit your abstract to [email protected] before September 19, 2026.

A limited number of sponsored Fellowships are available for select emerging researchers, innovators, and students. Contact [email protected] to inquire.

Program Overview:

• Networking Breakfast
• Keynote address: AI Transforming Drug Discovery, Clinical Development, and Patient Care
• Panel 1: Building Canada's AI-Driven Clinical Trial Ecosystem
• Panel 2: AI, Biomarkers and Precision Medicine
• Fireside Chat: Canada's AI Infrastructure for Healthcare Innovation
• Panel 3: AI Accelerating Drug Development and Regulatory Innovation
• Panel 4: Commercialization, Investment and Scaling Canadian Innovation
• Closing Keynote
• Networking Reception

Confirmed Speakers:

• Dr. Mario Masellis, Sunnybrook Health Sciences Centre (Keynote)
• Dr. Brad MacIntosh, University of Toronto
• Prof. Dr. Pedro Rosa Neto, McGill University